Jianjun Cheng

2.8k total citations · 2 hit papers
49 papers, 1.8k citations indexed

About

Jianjun Cheng is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Jianjun Cheng has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in Jianjun Cheng's work include Receptor Mechanisms and Signaling (19 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuropeptides and Animal Physiology (9 papers). Jianjun Cheng is often cited by papers focused on Receptor Mechanisms and Signaling (19 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuropeptides and Animal Physiology (9 papers). Jianjun Cheng collaborates with scholars based in China, United States and Italy. Jianjun Cheng's co-authors include Wenzhong Yan, Liang Tan, Sheng Wang, John D. McCorvy, Suwen Zhao, Luyu Fan, Zhangcheng Chen, Alan P. Kozikowski, Yiran Wu and Zhipu Luo and has published in prestigious journals such as Science, Cell and Chemical Reviews.

In The Last Decade

Jianjun Cheng

47 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

G protein-coupled receptors: structure- and function-based drug discovery

2021 395 citations Qingtong Zhou, Yiran Wu et al. profile →
Structure-based discovery of nonhallucinogenic psychedelic analogs

2022 200 citations Jing Yu, Huan Wang et al. Science profile →

Peers

Countries citing papers authored by Jianjun Cheng

Since Specialization

Citations

This map shows the geographic impact of Jianjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Cheng more than expected).

Fields of papers citing papers by Jianjun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Cheng. The network helps show where Jianjun Cheng may publish in the future.

Co-authorship network of co-authors of Jianjun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Cheng. A scholar is included among the top collaborators of Jianjun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Cheng. Jianjun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural basis of psychedelic LSD recognition at dopamine D1 receptor 2024 ·Neuron ·Luyu Fan, Youwen Zhuang, Hongyu Wu, (unknown), (unknown), Yue Wang, (unknown), Shishan Wang, Zhangcheng Chen, Jianjun Cheng, H. Eric Xu, Sheng Wang	3
2	2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jianjun Cheng	1
3	Psychedelics for treating psychiatric disorders: from circuit mechanisms to applications 2024 ·Science Bulletin ·Jie Li, (unknown), (unknown), Jianjun Cheng, Hu Ji, Xiaohui Wang, Ti‐Fei Yuan	0
4	Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases 2023 ·Chinese Chemical Letters ·Ruiquan Liu, (unknown), Wenzhong Yan, Jinfeng Zhang, Jianjun Cheng	8
5	Structure-based discovery of nonhallucinogenic psychedelic analogs breakdown → 2022 ·Science ·(unknown), Jing Yu, Huan Wang, Zhipu Luo, (unknown), (unknown), (unknown), Luyu Fan, (unknown), Zhangcheng Chen, Jinsong Li, Jianjun Cheng, Sheng Wang	200
6	The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands 2022 ·Nature Communications ·Jingjing Wang, Meng Wu, Zhangcheng Chen, Lijie Wu, Tian Wang, (unknown), Huan Wang, (unknown), Yueming Xu, Fei Li, Junlin Liu, (unknown), Suwen Zhao, Jianjun Cheng, Sheng Wang, Tian Hua	15
7	Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives 2022 ·European Journal of Medicinal Chemistry ·Jinfeng Zhang, Ziwei Luo, (unknown), Kexin Yang, Lijun Ling, Wenzhong Yan, Ruiquan Liu, Kurt Wüthrich, Hualiang Jiang, Chengying Xie, Jianjun Cheng	11
8	Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A_2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents 2021 ·Journal of Medicinal Chemistry ·Wenzhong Yan, Lijun Ling, Yiran Wu, Kexin Yang, Ruiquan Liu, Jinfeng Zhang, Simeng Zhao, Guisheng Zhong, Suwen Zhao, Hualiang Jiang, Chengying Xie, Jianjun Cheng	21
9	Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties 2021 ·Nature Neuroscience ·Zhangcheng Chen, Luyu Fan, Huan Wang, Jing Yu, Dengyu Lu, (unknown), Fen Nie, Zhipu Luo, Zhen Liu, Jianjun Cheng, Sheng Wang	43
10	Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands 2020 ·Journal of Medicinal Chemistry ·Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi‐Ping Huang, Jianjun Cheng	16
11	Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands 2020 ·Nature Communications ·Luyu Fan, Liang Tan, Zhangcheng Chen, (unknown), Fen Nie, Zhipu Luo, Jianjun Cheng, Sheng Wang	75
12	Revisit ligand-receptor interaction at the human vasopressin V2 receptor: A kinetic perspective 2020 ·European Journal of Pharmacology ·Chunji Liu, (unknown), (unknown), Xudong Cao, Wenzhong Yan, Jianjun Cheng, Thomas Roux, L. A. Peletier, Xiaoxing Yin, Dong Guo	9
13	Molecular compositions and structural properties of proteins in millet. 2019 ·Shipin Kexue / Food Science ·Lian‐Dong Guo, (unknown), (unknown), Yangyue Ding, Gaopeng Zhang, (unknown), Jianjun Cheng	3
14	Optimization of P2Y₁₂ Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties 2019 ·Journal of Medicinal Chemistry ·Deyu Kong, (unknown), Bin Guo, Jianjun Cheng, Shunying Liu, (unknown), Zhengyu Lu, Haoran Liu, Guoqing Gong, Tian Lan, Wenhao Hu, Yushe Yang	27
15	Design and synthesis of (2-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a selective serotonin 2C agonist 2015 ·Tetrahedron Letters ·Jianjun Cheng, Philippe Giguère, Wei Lv, Bryan L. Roth, Alan P. Kozikowski	14
16	Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents 2014 ·Bioorganic & Medicinal Chemistry Letters ·Jianjun Cheng, (unknown), (unknown), (unknown), (unknown)	12
17	CD8α⁺ and CD8α⁻ DC subsets from BCG‐infected mice inhibit allergic Th2‐cell responses by enhancing Th1‐cell and Treg‐cell activity respectively 2011 ·European Journal of Immunology ·Xiaoling Gao, Hong Bai, Jianjun Cheng, Yijun Fan, Shuhe Wang, Lei Jiao, (unknown), Xi Yang	15
18	Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand 2009 ·Schizophrenia Research ·(unknown), Hai Zhang, Xuetao Chen, (unknown), Jianjun Cheng, Yushe Yang, Guo-Zhang Jin, Xuechu Zhen	27
19	Estimation of the cortical functional connectivity with the multimodal integration of high-resolution EEG and fMRI data by directed transfer function 2004 ·NeuroImage ·Fabio Babiloni, Febo Cincotti, Claudio Babiloni, Filippo Carducci, Donatella Mattia, Laura Astolfi, A. Basilisco, Paolo Maria Rossini, Lei Ding, Y. Ni, Jianjun Cheng, Christine Katlama, John A. Sweeney, Bin He	327
20	Study on the enzyme browning mechanism of Pingguo pear and Duck pear 2000 ·Food Science ·Jianjun Cheng, Zhenxin Wang, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact